{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T07:26:39Z","timestamp":1787037999871,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00228-026-04133-4","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T03:49:16Z","timestamp":1784087356000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Medication adherence in breast cancer: a comparative analysis of self-report tools and prescription refill data"],"prefix":"10.1007","volume":"82","author":[{"given":"Abdel-Hameed I.","family":"Ebid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Elshewy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud I.","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Eid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Mobarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad","family":"Shash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"4133_CR1","doi-asserted-by":"publisher","first-page":"e2100289","DOI":"10.1200\/GO.21.00289","volume":"9","author":"DO Onwusah","year":"2023","unstructured":"Onwusah DO, Ojewole EB, Chimbari MJ (2023) Adherence to oral anticancer medications among women with breast cancer in africa: a scoping review. JCO Glob Oncol 9:e2100289. https:\/\/doi.org\/10.1200\/GO.21.00289","journal-title":"JCO Glob Oncol"},{"key":"4133_CR2","doi-asserted-by":"publisher","unstructured":"Lasala R, Santoleri F (2022) Association between adherence to oral therapies in cancer patients and clinical outcome: A systematic review of the literature. Br J Clin Pharmacol 88:1999\u20132018. https:\/\/doi.org\/10.1111\/bcp.15147","DOI":"10.1111\/bcp.15147"},{"key":"4133_CR3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10552-017-0851-9","volume":"28","author":"C Cahir","year":"2017","unstructured":"Cahir C, Barron TI, Sharp L, Bennett K (2017) Can demographic, clinical and treatment-related factors available at hormonal therapy initiation predict non-persistence in women with stage I\u2013III breast cancer? Cancer Causes Control 28:215\u2013225. https:\/\/doi.org\/10.1007\/s10552-017-0851-9","journal-title":"Cancer Causes Control"},{"key":"4133_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/cancers15010316","volume":"15","author":"C Bandiera","year":"2023","unstructured":"Bandiera C, Locatelli I, Courlet P, Cardoso E, Zaman K, Stravodimou A et al (2023) Adherence to the CDK 4\/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study. Cancers (Basel) 15:36. https:\/\/doi.org\/10.3390\/cancers15010316","journal-title":"Cancers (Basel)"},{"key":"4133_CR5","doi-asserted-by":"crossref","unstructured":"Cantrell CR, Eaddy MT, Shah MB, Regan TS, Sokol MC (2006) Methods for evaluating patient adherence to antidepressant therapy: a real-world comparison of adherence and economic outcomes. Med Care 44:300\u2013303. http:\/\/www.jstor.org\/stable\/3768321","DOI":"10.1097\/01.mlr.0000204287.82701.9b"},{"key":"4133_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.breast.2022.01.012","volume":"62","author":"I Yussof","year":"2022","unstructured":"Yussof I, Mohd Tahir NA, Hatah E, Mohamed Shah N (2022) Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: a systematic review. Breast 62:22\u201335. https:\/\/doi.org\/10.1016\/j.breast.2022.01.012","journal-title":"Breast"},{"key":"4133_CR7","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2147\/PPA.S352161","volume":"16","author":"RI Nassar","year":"2022","unstructured":"Nassar RI, Basheti IA, Saini B (2022) Exploring validated self-reported instruments to assess adherence to medications used: a review comparing existing instruments. Patient Prefer Adher 16:503\u2013513. https:\/\/doi.org\/10.2147\/PPA.S352161","journal-title":"Patient Prefer Adher"},{"key":"4133_CR8","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1186\/1471-2407-12-474","volume":"12","author":"AS Oberguggenberger","year":"2012","unstructured":"Oberguggenberger AS, Sztankay M, Beer B, Schubert B, Meraner V, Oberacher H et al (2012) Adherence evaluation of endocrine treatment in breast cancer: methodological aspects. BMC Cancer 12:474. https:\/\/doi.org\/10.1186\/1471-2407-12-474","journal-title":"BMC Cancer"},{"key":"4133_CR9","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1188\/16.ONF.576-582","volume":"43","author":"T Atkinson","year":"2016","unstructured":"Atkinson T, Rodr\u00edguez V, Gordon M, Avildsen I, Emanu J, Jewell S et al (2016) The association between patient-reported and objective oral anticancer medication adherence measures: a systematic review. Oncol Nurs Forum 43:576\u2013582. https:\/\/doi.org\/10.1188\/16.ONF.576-582","journal-title":"Oncol Nurs Forum"},{"key":"4133_CR10","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/bjc.2012.389","volume":"107","author":"R Font","year":"2012","unstructured":"Font R, Espinas JA, Gil-Gil M, Barnadas A, Ojeda B, Tusquets I et al (2012) Prescription refill, patient self-report and physician report in assessing adherence to oral endocrine therapy in early breast cancer patients: a retrospective cohort study in Catalonia, Spain. Br J Cancer 107:1249\u20131256. https:\/\/doi.org\/10.1038\/bjc.2012.389","journal-title":"Br J Cancer"},{"key":"4133_CR11","doi-asserted-by":"publisher","first-page":"oyag168","DOI":"10.1093\/oncolo\/oyag168","volume":"31","author":"D Mourath","year":"2026","unstructured":"Mourath D, Fohlin H (2026) Adherence to oral antineoplastic agents, an overview and meta-analysis. Oncologist 31:oyag168. https:\/\/doi.org\/10.1093\/oncolo\/oyag168","journal-title":"Oncologist"},{"key":"4133_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcsop.2025.100682","volume":"20","author":"A-HIM Ebid","year":"2025","unstructured":"Ebid A-HIM, Elshewy R, Mostafa MI, Eid R, Shash E, Mobarez MA (2025) Adherence to oral anticancer medications in metastatic versus nonmetastatic breast cancer patients: insights from a low-middle-income country. Explor Res Clin Soc Pharm 20:100682. https:\/\/doi.org\/10.1016\/j.rcsop.2025.100682","journal-title":"Explor Res Clin Soc Pharm"},{"key":"4133_CR13","doi-asserted-by":"crossref","unstructured":"Refaat Elmaadawy A, Salah Hassan M, Mohamed Mohamed Y, Eldin Moussa Sherif D (2022) Factors affecting adherence to adjuvant hormonal therapy among women with breast cancer. Egypt J Health Care 13(4):1033-1049","DOI":"10.21608\/ejhc.2022.266528"},{"key":"4133_CR14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1524-4733.2008.00400.x","volume":"12","author":"S Kripalani","year":"2009","unstructured":"Kripalani S, Risser J, Gatti ME, Jacobson TA (2009) Development and evaluation of the adherence to refills and medications scale (ARMS) among low-literacy patients with chronic disease. Value Health 12:118\u2013123. https:\/\/doi.org\/10.1111\/j.1524-4733.2008.00400.x","journal-title":"Value Health"},{"key":"4133_CR15","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1111\/bcp.14193","volume":"86","author":"AHY Chan","year":"2020","unstructured":"Chan AHY, Horne R, Hankins M, Chisari C (2020) The medication adherence report scale: a measurement tool for eliciting patients\u2019 reports of nonadherence. Br J Clin Pharmacol 86:1281\u20131288. https:\/\/doi.org\/10.1111\/bcp.14193","journal-title":"Br J Clin Pharmacol"},{"key":"4133_CR16","unstructured":"Saeed N, Ettienne EB (2020) Translation and validation of a simplified medication adherence questionnaire and factors affecting chronic diseases medication adherence among arab americans. ProQuest Dissertations and Theses. [United States -- District of Columbia]. https:\/\/www.proquest.com\/dissertations-theses\/translation-validation-simplified-medication\/docview\/2451414723\/se-2?accountid=178282"},{"key":"4133_CR17","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1097\/00002030-200203080-00012","volume":"16","author":"H Knobel","year":"2002","unstructured":"Knobel H, Alonso J, Casado JL, Collazos J, Gonz\u00e1lez J, Ruiz I et al (2002) Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study. AIDS 16:605\u2013613. https:\/\/doi.org\/10.1097\/00002030-200203080-00012","journal-title":"AIDS"},{"key":"4133_CR18","doi-asserted-by":"crossref","unstructured":"Ashur ST, Shamsuddin K, Shah SA, Bosseri S, Morisky DE (2015) Reliability and known-group validity of the Arabic version of the 8-item Morisky Medication Adherence Scale among type 2 diabetes mellitus patients \u0640\u0643\u0631\u064a\u202c \u0627\u0644\u0633\u0640\u202c \u0640\u0631\u0649\u0636\u202c \u0645\u0640\u202c \u0640\u0646\u202c \u0628\u0640\u202c \u0640\u062f\u0627\u0648\u0627\u0629\u202c \u0628\u0627\u0645\u0644\u0640\u202c \u0640\u0632\u0627\u0645\u202c \u0628\u0627\u0627\u0644\u0644\u062a\u0640\u202c \u0640\u0627\u0635\u202c \u0627\u062e\u0644\u0640\u202c \u0640\u0629\u202c \u0627\u0644\u062b\u0627\u0645\u0646\u064a\u0640\u202c \u0640\u0648\u062f\u202c \u0627\u0644\u0628\u0646\u0640\u202c \u0630\u064a\u202c \u0640\u0643\u064a\u202c \u0645\u0648\u0631\u064a\u0633\u0640\u202c \u0640\u0627\u0633\u202c \u0645\u0642\u064a\u0640\u202c \u0640\u0646\u202c \u0645\u0640\u202c \u0640\u0629\u202c \u0627\u0644\u0639\u0631\u0628\u064a\u0640\u202c \u0640\u062e\u0629\u202c \u0627\u0644\u0646\u0633\u0640\u202c \u0640\u0629\u202c \u0645\u0648\u062b\u0648\u0642\u064a\u0640\u202c \u0640\u0629\u202c \u0645\u0639\u0631\u0648\u0641\u0640\u202c \u0640\u0627\u062a\u202c \u062c\u0645\u0645\u0648\u0639\u0640\u202c \u0640\u062f\u0649\u202c \u0644\u0640\u202c \u0640\u062e\u0629\u202c \u0627\u0644\u0646\u0633\u0640\u202c \u0640\u0630\u0647\u202c \u0647\u0640\u202c \u0640\u0629\u202c \u0648\u0645\u0635\u062f\u0627\u0642\u064a\u0640\u202c \u060c2 \u0640\u0637\u202c \u0627\u0644\u0646\u0645\u0640\u202c \u0640\u0646\u202c \u0645\u0640\u202c. Eastern Mediterranean Health Journal.","DOI":"10.26719\/2015.21.10.722"},{"key":"4133_CR19","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJMoa1611179","volume":"377","author":"DR Berlowitz","year":"2017","unstructured":"Berlowitz DR, Foy CG, Kazis LE, Bolin LP, Conroy MB, Fitzpatrick P et al (2017) Effect of intensive blood-pressure treatment on patient-reported outcomes. N Engl J Med 377:733\u2013744. https:\/\/doi.org\/10.1056\/NEJMoa1611179","journal-title":"N Engl J Med"},{"key":"4133_CR20","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1056\/nejmsa1616035","volume":"377","author":"AP Bress","year":"2017","unstructured":"Bress AP, Bellows BK, King JB, Hess R, Beddhu S, Zhang Z et al (2017) Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control. N Engl J Med 377:745\u201355. https:\/\/doi.org\/10.1056\/nejmsa1616035","journal-title":"N Engl J Med"},{"key":"4133_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187139","volume":"12","author":"SJ Moon","year":"2017","unstructured":"Moon SJ, Lee W-Y, Hwang JS, Hong YP, Morisky DE (2017) Accuracy of a screening tool for medication adherence: a systematic review and meta-analysis of the Morisky Medication Adherence Scale-8. PLoS ONE 12:e0187139. https:\/\/doi.org\/10.1371\/journal.pone.0187139","journal-title":"PLoS ONE"},{"key":"4133_CR22","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1590\/S0066-782X2012005000053","volume":"99","author":"AD Oliveira-Filho","year":"2012","unstructured":"Oliveira-Filho AD, Barreto-Filho JA, Neves SJF, Lyra Junior DPde (2012) Rela\u00e7\u00e3o entre a Escala de Ades\u00e3o Terap\u00eautica de oito itens de Morisky (MMAS-8) e o controle da press\u00e3o arterial. Arq Bras Cardiol 99:649\u2013658. https:\/\/doi.org\/10.1590\/S0066-782X2012005000053","journal-title":"Arq Bras Cardiol"},{"key":"4133_CR23","doi-asserted-by":"publisher","DOI":"10.18433\/J3SW36","author":"BE Egbewale","year":"2014","unstructured":"Egbewale BE (2014) Random allocation in controlled clinical trials: a review. J Pharm Pharm Sci. https:\/\/doi.org\/10.18433\/J3SW36","journal-title":"J Pharm Pharm Sci"},{"key":"4133_CR24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.4097\/KJA.21165","volume":"74","author":"CY Lim","year":"2021","unstructured":"Lim CY, In J (2021) Considerations for crossover design in clinical study. Korean J Anesthesiol 74:293\u20139. https:\/\/doi.org\/10.4097\/KJA.21165","journal-title":"Korean J Anesthesiol"},{"key":"4133_CR25","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1136\/bmj.316.7146.1719","volume":"316","author":"B Sibbald","year":"1998","unstructured":"Sibbald B, Roberts C (1998) Understanding controlled trials crossover trials. BMJ 316:1719. https:\/\/doi.org\/10.1136\/bmj.316.7146.1719","journal-title":"BMJ"},{"key":"4133_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-024-08310-7","volume":"25","author":"G Albalak","year":"2024","unstructured":"Albalak G, Noordam R, van der Elst M, Kervezee L, Exadaktylos V, van Bodegom D et al (2024) Older adults exercising on time: protocol for a randomized controlled cross-over study to assess the effect of physical activity timing on insomnia severity. Trials 25:523. https:\/\/doi.org\/10.1186\/s13063-024-08310-7","journal-title":"Trials"},{"key":"4133_CR27","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.2147\/PPA.S319087","volume":"15","author":"KI Toivonen","year":"2021","unstructured":"Toivonen KI, Carlson LE, Rash JA, Campbell TS (2021) A survey of potentially modifiable patient-level factors associated with self-report and objectively measured adherence to adjuvant endocrine therapies after breast cancer. Patient Prefer Adher 15:2039\u201350. https:\/\/doi.org\/10.2147\/PPA.S319087","journal-title":"Patient Prefer Adher"},{"key":"4133_CR28","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1080\/03007995.2017.1321534","volume":"33","author":"S Malo","year":"2017","unstructured":"Malo S, Aguilar-Palacio I, Feja C, Lallana MJ, Rabanaque MJ, Armesto J et al (2017) Different approaches to the assessment of adherence and persistence with cardiovascular-disease preventive medications. Curr Med Res Opin 33:1329\u20131336. https:\/\/doi.org\/10.1080\/03007995.2017.1321534","journal-title":"Curr Med Res Opin"},{"key":"4133_CR29","doi-asserted-by":"publisher","unstructured":"Raebel MA, Schmittdiel J, Karter AJ, Konieczny JL, Steiner JF (2013) Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases 51. https:\/\/doi.org\/10.1097\/MLR.0b013e31829b1d2a","DOI":"10.1097\/MLR.0b013e31829b1d2a"},{"key":"4133_CR30","doi-asserted-by":"publisher","unstructured":"Dragvoll I, Bofin AM, S\u00f8iland H, Taraldsen G, Engstr\u00f8m MJ (2022) Predictors of adherence and the role of primary non-adherence in antihormonal treatment of breast cancer. BMC Cancer 22. https:\/\/doi.org\/10.1186\/s12885-022-10362-4","DOI":"10.1186\/s12885-022-10362-4"},{"key":"4133_CR31","doi-asserted-by":"publisher","unstructured":"Lam WY, Fresco P (2015) Medication adherence measures: an overview. Biomed Res Int 2015:217047. https:\/\/doi.org\/10.1155\/2015\/217047","DOI":"10.1155\/2015\/217047"},{"key":"4133_CR32","doi-asserted-by":"publisher","first-page":"801","DOI":"10.18553\/jmcp.2016.22.7.801","volume":"22","author":"CA Lester","year":"2016","unstructured":"Lester CA, Mott DA, Chui MA (2016) The influence of a community pharmacy automatic prescription refill program on Medicare Part D adherence metrics. J Manag Care Spec Pharm 22:801\u2013807. https:\/\/doi.org\/10.18553\/jmcp.2016.22.7.801","journal-title":"J Manag Care Spec Pharm"},{"key":"4133_CR33","doi-asserted-by":"publisher","unstructured":"Landis JR, Koch GG (1977) The Measurement of observer agreement for categorical data. Biometrics 33:159\u201374. https:\/\/doi.org\/10.2307\/2529310","DOI":"10.2307\/2529310"},{"key":"4133_CR34","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1097\/JTO.0b013e3181ec173d","volume":"5","author":"JN Mandrekar","year":"2010","unstructured":"Mandrekar JN (2010) Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol 5:1315\u20131316. https:\/\/doi.org\/10.1097\/JTO.0b013e3181ec173d","journal-title":"J Thorac Oncol"},{"key":"4133_CR35","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04167.x","volume":"73","author":"B Vrijens","year":"2012","unstructured":"Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T et al (2012) A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol 73:691\u2013705. https:\/\/doi.org\/10.1111\/j.1365-2125.2012.04167.x","journal-title":"Br J Clin Pharmacol"},{"key":"4133_CR36","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s13142-015-0315-2","volume":"5","author":"MJ Stirratt","year":"2015","unstructured":"Stirratt MJ, Dunbar-Jacob J, Crane HM, Simoni JM, Czajkowski S, Hilliard ME et al (2015) Self-report measures of medication adherence behavior: recommendations on optimal use. Transl Behav Med 5:470\u2013482. https:\/\/doi.org\/10.1007\/s13142-015-0315-2","journal-title":"Transl Behav Med"},{"key":"4133_CR37","doi-asserted-by":"publisher","unstructured":"Partridge AH, Avorn J, Wang PS, Winer EP (2002) Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst 94:652\u201361. https:\/\/doi.org\/10.1093\/jnci\/94.9.652","DOI":"10.1093\/jnci\/94.9.652"},{"key":"4133_CR38","doi-asserted-by":"publisher","DOI":"10.1093\/abm\/kaab080","author":"P Konstantinou","year":"2021","unstructured":"Konstantinou P, Kasinopoulos O, Karashiali C, Georgiou G, Panayides A, Papageorgiou A et al (2021) A scoping review of methods used to assess medication adherence in patients with chronic conditions. Ann Behav Med. https:\/\/doi.org\/10.1093\/abm\/kaab080","journal-title":"Ann Behav Med"},{"key":"4133_CR39","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/1471-2288-11-149","volume":"11","author":"S Garfield","year":"2011","unstructured":"Garfield S, Clifford S, Eliasson L, Barber N, Willson A (2011) Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review. BMC Med Res Methodol 11:149. https:\/\/doi.org\/10.1186\/1471-2288-11-149","journal-title":"BMC Med Res Methodol"},{"key":"4133_CR40","doi-asserted-by":"publisher","unstructured":"Raebel Marsha A, Carroll Nikki M, Ellis Jennifer L, Schroeder Emily B, Bayliss Elizabeth A (2011) Importance of including early nonadherence in estimations of medication adherence. Ann Pharmacother 45:1053\u201360. https:\/\/doi.org\/10.1345\/aph.1Q146","DOI":"10.1345\/aph.1Q146"},{"key":"4133_CR41","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s10549-022-06518-2","volume":"192","author":"CC Conley","year":"2022","unstructured":"Conley CC, McIntyre M, Pensak NA, Lynce F, Graham D, Ismail-Khan R et al (2022) Barriers and facilitators to taking CDK4\/6 inhibitors among patients with metastatic breast cancer: a qualitative study. Breast Cancer Res Treat 192:385\u2013399. https:\/\/doi.org\/10.1007\/s10549-022-06518-2","journal-title":"Breast Cancer Res Treat"},{"key":"4133_CR42","doi-asserted-by":"publisher","unstructured":"Brito C, Portela MC, de Vasconcellos MTL (2014) Adherence to hormone therapy among women with breast cancer. BMC Cancer 14. https:\/\/doi.org\/10.1186\/1471-2407-14-397","DOI":"10.1186\/1471-2407-14-397"},{"key":"4133_CR43","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3390\/curroncol30020112","volume":"30","author":"R Rosso","year":"2023","unstructured":"Rosso R, D\u2019Alonzo M, Bounous VE, Actis S, Cipullo I, Salerno E et al (2023) Adherence to adjuvant endocrine therapy in breast cancer patients. Current Oncology MDPI 30:1461\u20131472. https:\/\/doi.org\/10.3390\/curroncol30020112","journal-title":"Current Oncology MDPI"},{"key":"4133_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/edbk_320595","volume":"41","author":"I Vaz-Luis","year":"2021","unstructured":"Vaz-Luis I, Francis PA, Di Meglio A, Stearns V (2021) Challenges in Adjuvant Therapy for Premenopausal Women Diagnosed With Luminal Breast Cancers. Am Soc Clin Oncol Educ Book 41:1\u201315. https:\/\/doi.org\/10.1200\/edbk_320595","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"1","key":"4133_CR45","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3390\/cancers13010107","volume":"13","author":"KI Toivonen","year":"2021","unstructured":"Toivonen KI, Williamson TM, Carlson LE, Walker LM, Campbell TS (2021) Potentially modifiable factors associated with adherence to adjuvant endocrine therapy among breast cancer survivors: A systematic review. Cancers (Basel) 13(1):107. https:\/\/doi.org\/10.3390\/cancers13010107","journal-title":"Cancers (Basel)"},{"key":"4133_CR46","doi-asserted-by":"publisher","unstructured":"Sawesi S, Carpenter JS, Jones J (2014) Reasons for nonadherence to tamoxifen and aromatase inhibitors for the treatment of breast cancer: a literature review. Clin J Oncol Nurs 18. https:\/\/doi.org\/10.1188\/14.CJON.E50-E57","DOI":"10.1188\/14.CJON.E50-E57"},{"key":"4133_CR47","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","volume":"11","author":"JA Cramer","year":"2008","unstructured":"Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA et al (2008) Medication compliance and persistence: terminology and definitions. Value Health 11:44\u201347. https:\/\/doi.org\/10.1111\/j.1524-4733.2007.00213.x","journal-title":"Value Health"},{"key":"4133_CR48","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jval.2018.08.006","volume":"22","author":"PP Pednekar","year":"2019","unstructured":"Pednekar PP, \u00c1gh T, Malmen\u00e4s M, Raval AD, Bennett BM, Borah BJ et al (2019) Methods for measuring multiple medication adherence: a systematic review-report of the ISPOR medication adherence and persistence special interest group. Value Health 22:139\u2013156. https:\/\/doi.org\/10.1016\/j.jval.2018.08.006","journal-title":"Value Health"},{"key":"4133_CR49","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2147\/CLEP.S333534","volume":"13","author":"M Asamoah-Boaheng","year":"2021","unstructured":"Asamoah-Boaheng M, Bonsu KO, Farrell J, Oyet A, Midodzi WK (2021) Measuring medication adherence in a population-based asthma administrative pharmacy database: a systematic review and meta-analysis. Clin. Epidemiol 13:981\u20131010. https:\/\/doi.org\/10.2147\/CLEP.S333534","journal-title":"Clin. Epidemiol"},{"key":"4133_CR50","doi-asserted-by":"publisher","unstructured":"Driesenaar, van Steenis, Bensing, van Hulten, Souverein, van Dijk L, et al (2014) Relationship between medication beliefs, self-reported and refill adherence, and symptoms in patients with asthma using inhaled corticosteroids. Patient Prefer Adhere 83. https:\/\/doi.org\/10.2147\/PPA.S44185","DOI":"10.2147\/PPA.S44185"},{"key":"4133_CR51","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s00228-022-03284-4","volume":"78","author":"H Norberg","year":"2022","unstructured":"Norberg H, Sj\u00f6lander M, Glader E-L, Gustafsson M (2022) Self-reported medication adherence and pharmacy refill adherence among persons with ischemic stroke: a cross-sectional study. Eur J Clin Pharmacol 78:869\u2013877. https:\/\/doi.org\/10.1007\/s00228-022-03284-4","journal-title":"Eur J Clin Pharmacol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04133-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-026-04133-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04133-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:55:40Z","timestamp":1787036140000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-026-04133-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["4133"],"URL":"https:\/\/doi.org\/10.1007\/s00228-026-04133-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8642278\/v1","asserted-by":"object"}]},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research was conducted in accordance with the principles of the Declaration of Helsinki. The IRB of Cairo University\u2019s National Cancer Institute authorized the study (Approval number; 2310\u2013105-003, approval date; 7\/11\/2023).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants in the research provided informed consent.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"207"}}